Lack of IT specialists could hamper life science growth

Novo Nordisk and the Danish Chamber of Commerce warn that the Danish life science industry will need more hands, especially within IT, if the growth seen over the past decades is to continue. Investments in education and international recruitment are two parts of the solution, they say.

Photo: Thomas Borberg

Over the past few decades, the Danish life science sector has grown to become one of the most important cornerstones in the country’s industry. The sector generated a total revenue of just under DKK 250bn (USD 36.8bn) in 2018, and in 2020, life science exports surpassed DKK 150bn (USD 22.1bn) – equating to a fifth of Danish exports. The sector also paid more than DKK 24bn (USD 3.5bn) in taxes in the country.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs